Skip to Main Content

Author Details

Ann Marie Egloff
Harvard Medical School, Brigham and Women's Hospital
1992
95
42
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36747644Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multi-cancer biomarker.bioRxiv2023
37837735Circulating tumor-tissue modified HPV DNA testing in the clinical evaluation of patients at risk for HPV-positive oropharynx cancer: The IDEA-HPV study.Oral Oncol2023
37683037Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer.Sci Immunol2023
36747644Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multi-cancer biomarker.bioRxiv2023
36990508Identification of HPV16 E1 and E2-specific T cells in the oropharyngeal cancer tumor microenvironment.J Immunother Cancer2023
37837735Circulating tumor-tissue modified HPV DNA testing in the clinical evaluation of patients at risk for HPV-positive oropharynx cancer: The IDEA-HPV study.Oral Oncol2023
37683037Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer.Sci Immunol2023
36990508Identification of HPV16 E1 and E2-specific T cells in the oropharyngeal cancer tumor microenvironment.J Immunother Cancer2023
34667025Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck.Clin Cancer Res2022
35705032YAP1 maintains active chromatin state in head and neck squamous cell carcinomas that promotes tumorigenesis through cooperation with BRD4.Cell Rep2022
36357512Graph deep learning for the characterization of tumour microenvironments from spatial protein profiles in tissue specimens.Nat Biomed Eng2022
35820346The mouse oral carcinoma (MOC) model: A 10-year retrospective on model development and head and neck cancer investigations.Oral Oncol2022
36875716Correction: Comprehensive Immunoprofiling of High-risk Oral Proliferative and Localized Leukoplakia.Cancer Res Commun2022
35256551Preoperative immunotherapy for head and neck cancers: state of art.Curr Opin Oncol2022
34667025Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck.Clin Cancer Res2022
35058328Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders.J Immunother Cancer2022
35705032YAP1 maintains active chromatin state in head and neck squamous cell carcinomas that promotes tumorigenesis through cooperation with BRD4.Cell Rep2022
35820346The mouse oral carcinoma (MOC) model: A 10-year retrospective on model development and head and neck cancer investigations.Oral Oncol2022
36875716Correction: Comprehensive Immunoprofiling of High-risk Oral Proliferative and Localized Leukoplakia.Cancer Res Commun2022
36357512Graph deep learning for the characterization of tumour microenvironments from spatial protein profiles in tissue specimens.Nat Biomed Eng2022
35256551Preoperative immunotherapy for head and neck cancers: state of art.Curr Opin Oncol2022
35058328Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders.J Immunother Cancer2022
33397681Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-unrelated Head and Neck Cancer: A Multicenter, Phase II Trial.Clin Cancer Res2021
36860910Comprehensive Immunoprofiling of High-Risk Oral Proliferative and Localized Leukoplakia.Cancer Res Commun2021
33643653Tumor-associated neutrophils (TANs) in human carcinoma-draining lymph nodes: a novel TAN compartment.Clin Transl Immunology2021
33547198Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas.Clin Cancer Res2021
33368875Personalized cancer vaccination in head and neck cancer.Cancer Sci2021
33397681Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-unrelated Head and Neck Cancer: A Multicenter, Phase II Trial.Clin Cancer Res2021
34408919Integrating CD4<sup>+</sup> T cell help for therapeutic cancer vaccination in a preclinical head and neck cancer model.Oncoimmunology2021
36860910Comprehensive Immunoprofiling of High-Risk Oral Proliferative and Localized Leukoplakia.Cancer Res Commun2021
33547198Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas.Clin Cancer Res2021
33643653Tumor-associated neutrophils (TANs) in human carcinoma-draining lymph nodes: a novel TAN compartment.Clin Transl Immunology2021
34408919Integrating CD4<sup>+</sup> T cell help for therapeutic cancer vaccination in a preclinical head and neck cancer model.Oncoimmunology2021
33368875Personalized cancer vaccination in head and neck cancer.Cancer Sci2021
30029671Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer.Genome Med2018
30029671Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer.Genome Med2018
28559019IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancer.Oral Oncol2017
28559019IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancer.Oral Oncol2017
27004400MAPK1E322K mutation increases head and neck squamous cell carcinoma sensitivity to erlotinib through enhanced secretion of amphiregulin.Oncotarget2016
27004400MAPK1E322K mutation increases head and neck squamous cell carcinoma sensitivity to erlotinib through enhanced secretion of amphiregulin.Oncotarget2016
26685214Proteomic Characterization of Head and Neck Cancer Patient-Derived Xenografts.Mol Cancer Res2016
26685214Proteomic Characterization of Head and Neck Cancer Patient-Derived Xenografts.Mol Cancer Res2016
24931169Cellular senescence checkpoint function determines differential Notch1-dependent oncogenic and tumor-suppressor activities.Oncogene2015
25658924Challenges in EGFRvIII detection in head and neck squamous cell carcinoma.PLoS One2015
25511740Identification of epidermal growth factor receptor (EGFR) genetic variants that modify risk for head and neck squamous cell carcinoma.Cancer Lett2015
26181029Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma.JAMA Oncol2015
24931169Cellular senescence checkpoint function determines differential Notch1-dependent oncogenic and tumor-suppressor activities.Oncogene2015
26181029Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma.JAMA Oncol2015
25658924Challenges in EGFRvIII detection in head and neck squamous cell carcinoma.PLoS One2015
25511740Identification of epidermal growth factor receptor (EGFR) genetic variants that modify risk for head and neck squamous cell carcinoma.Cancer Lett2015
  • 1 - 50 of 190

Recommended Authors

Eric Paquet
University of Laval
Career Start Year 2007
Number of shared co-authors 0
Lisa M Miller Jenkins
National Cancer Institute, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 0
Abul Kalam Azad
University of Dhaka
Career Start Year 2004
Number of shared co-authors 0
Antonio L Amelio
University of North Carolina at Chapel Hill
Career Start Year 2004
Number of shared co-authors 1
Yi-Ting Wang
McGill Research Centre for Studies in Aging
Career Start Year 2003
Number of shared co-authors 0
Kathrin Scheckenbach
Heinrich-Heine University
Career Start Year 2002
Number of shared co-authors 0
Osvaldo Gra??a
Spanish National Cancer Research Centre-CNIO
Career Start Year 2002
Number of shared co-authors 0
Hyunseok Kang
Johns Hopkins University
Career Start Year 2000
Number of shared co-authors 7
Christopher J Howlett
Western University
Career Start Year 1999
Number of shared co-authors 2
Kenneth D Westover
University of Texas Southwestern Medical Center
Career Start Year 1998
Number of shared co-authors 1
Dongquan Chen
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
Ji Eun Oh
College of Science & Industry Convergence, Ewha Womans University
Career Start Year 1997
Number of shared co-authors 0
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
Mitchell J Frederick
Baylor College of Medicine
Career Start Year 1995
Number of shared co-authors 6
Yu-Tsueng Liu
University of California San Diego
Career Start Year 1994
Number of shared co-authors 1
Peter Kuhn
University of Tubingen
Career Start Year 1994
Number of shared co-authors 0
Mark W Lingen
University of Chicago Pritzker School of Medicine
Career Start Year 1993
Number of shared co-authors 9
Jenny Xiang
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 1993
Number of shared co-authors 0
Bhuvanesh Singh
Memorial Sloan Kettering Cancer Center
Career Start Year 1991
Number of shared co-authors 3
Ming-Hui Wei
Yantai Affiliated Hospital of Binzhou Medical University
Career Start Year 1991
Number of shared co-authors 0
Wenbin Wei
Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield
Career Start Year 1991
Number of shared co-authors 0
Aykut Uren
Georgetown University Medical Center
Career Start Year 1991
Number of shared co-authors 0
Jong-Il Kim
Genomic Medicine Institute, Medical Research Center, Seoul National University
Career Start Year 1989
Number of shared co-authors 0
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 2
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 3
Philip J R Day
University of Cape Town
Career Start Year 1988
Number of shared co-authors 2
Eivind Hovig
Center for Bioinformatics, University of Oslo
Career Start Year 1987
Number of shared co-authors 0
Wendell G Yarbrough
University of North Carolina at Chapel Hill
Career Start Year 1986
Number of shared co-authors 10
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 9
Joseph A Califano
University of California
Career Start Year 1977
Number of shared co-authors 10

Collaborators

Jennifer R Grandis
University of California san francisco
Co-authored papers 28
Ravindra Uppaluri
Brigham and Women's Hospital
Co-authored papers 17
Christian Cambillau
Aix Marseille University and CNRS
Co-authored papers 15
Raja R Seethala
University of Pittsburgh Medical Center-Presbyterian
Co-authored papers 11
Lin Wang
Co-authored papers 9
Robert I Haddad
Dana-Farber Cancer Institute, Harvard Medical School
Co-authored papers 5
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 4
Umamaheswar Duvvuri
University of Pittsburgh School of Medicine
Co-authored papers 4
Katie M Campbell
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 3
Joel L Weissfeld
Co-authored papers 3
Hua Li
University of California san francisco
Co-authored papers 3
Julie E Bauman
George Washington University
Co-authored papers 3
Obi L Griffith
Washington University
Co-authored papers 3
Alexander E Gorbalenya
Leiden University Medical Center
Co-authored papers 2
Marjorie Romkes
Co-authored papers 2
Aaron McKenna
Co-authored papers 2
Alessandro Villa
Co-authored papers 2
Gavin P Dunn
Washington University School of Medicine
Co-authored papers 2
Zachary L Skidmore
Washington University in St. Louis School of Medicine
Co-authored papers 2
Todd R Golub
Broad Institute of MIT and Harvard
Co-authored papers 2
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 2
John Ziebuhr
Institute of Medical Virology Justus Liebig University
Co-authored papers 2
Yan Zeng
Department of Pharmacy, Affiliated Hospital of North Sichuan Medical College
Co-authored papers 2
Nicolas Stransky
Co-authored papers 2
Stephen Y Lai
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Scott L Carter
Co-authored papers 2
Malachi Griffith
Washington University
Co-authored papers 2
Levi A Garraway
Broad Institute of Harvard and MIT
Co-authored papers 2
Matthew Meyerson
Broad Institute
Co-authored papers 2
Erica K Barnell
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 2
Release 1.2